NSABP Biospecimen Discovery Project
Protocol Chair :Matthew Ellis, MB, BChir, PhD
Protocol Officer: Samuel Jacobs, MD
Primary Objective:The primary aim of this study is to determine the feasibility of comprehensive tumor 'omics profiling in patients receiving an upfront regimen containing a taxane plus HER (antibody[ies] or
Patient Population: Operable and Locally Advanced HER2-Positive Breast Cancer
Target Accrual: 50 patients
Status: Recruiting participants
ClinicalTrials.gov Identifier: NCT01850628
The Mission of NSABP Foundation, Inc. is to design and conduct practice changing cancer research, including clinical trials and laboratory studies in the medical, surgical and prevention settings in order to improve the survival outcome and quality of life of patients with breast and colorectal cancer, and to disseminate the results of NSABP collaborative research to benefit the world-wide community.
NSABP Foundation Inc.
Nova Tower 2
Two Allegheny Center – Suite 1200
Pittsburgh, PA 15212-5402